terbinafine
D - Dermatologicals -> D01 - Antifungals For Dermatological Use -> D01B - Antifungals For Systemic Use -> D01BA - Antifungals For Systemic Use -> D01BA02 - Terbinafine
Administration category:
Free
Medicine group:
antifungal
Brand name:
Lamisil
Safety margins
| Weight | ROA | Dosage |
|---|---|---|
|
ROA: po |
Dosage: 250mg 1 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: <50 |
Dosage: 125 mg 1dd |
|||
Renal elimination:
0%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: po: 125 mg 1 dd
Hemo dialysis: po: 125 mg 1 dd
CAV / VVHD: po: 125 mg 1 dd
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-500481.1
Updated: 09/09/2021 - 16:38
Status: Published